News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ASTRO Release: Memantine Delays Cognitive Decline in Brain Tumor Patients Who Receive Whole Brain Radiation Therapy


10/29/2012 9:41:55 AM

BOSTON, Oct. 29, 2012 (GLOBE NEWSWIRE) -- Memantine, an N-Methyl-D-aspartate receptor antagonist typically prescribed to Alzheimer's patients, slows cognitive decline in brain cancer patients who receive whole brain radiation therapy (WBRT), according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 54th Annual Meeting.

Read at GlobeNewswire


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES